COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,625 Articles (22,913 medRxiv, 8,712 bioRxiv)

Most recent first Previous |  Page 2454: Articles 24531-24540  | Next

Impact Assessment of Full and Partial Stay-at-Home Orders, Face Mask Usage, and Contact Tracing: An Agent-Based Simulation Study of COVID-19 for an Urban Region
Tatapudi, H., Das, R., Das, T. K.
10.1101/2020.07.27.20163121 — Posted: 2020-07-29
Risk Factors for COVID-19-associated hospitalization: COVID-19-Associated Hospitalization Surveillance Network and Behavioral Risk Factor Surveillance System
Ko, J. Y., Danielson, M. L., Town, M., Derado, G., Greenland, K. J., Daily Kirley, P., Alden, N. B., Yousey-Hindes, K., Anderson, E. J., Ryan, P. A., Kim, S., Lynfield, R., Torres, S. M., Barney, G. R., Bennett, N. M., Sutton, M., Talbot, H. K., Hill, M., Hall, A. J., Fry, A. M., Garg, S., Kim, L., COVID-NET Investigation Group
10.1101/2020.07.27.20161810 — Posted: 2020-07-29
The effective reproductive number (Rt) of COVID-19 and its relationship with social distancing
Jardim, L., Diniz-Filho, J. A., Rangel, T. F., Toscano, C. M.
10.1101/2020.07.28.20163493 — Posted: 2020-07-29
Prevalence of amyloid blood clots in COVID-19 plasma
Pretorius, E., Venter, C., Laubscher, G. J., Lourens, P. J., Steenkamp, J., Kell, D. B.
10.1101/2020.07.28.20163543 — Posted: 2020-07-29
Evaluation of a SARS-CoV-2 surrogate virus neutralization test for detection of antibody in human, canine, cat and hamster sera
Peiris, J. S. M., Perera, R. A.
10.1101/2020.07.28.20163592 — Posted: 2020-07-29
Sensitive detection of SARS-CoV-2 seroconversion by flow cytometry reveals the presence of nucleoprotein-reactive antibodies in Covid-19-naive individuals
Egia-Mendikute, L., Bosch, A., Prieto-Fernandez, E., Lee, S. Y., Jimenez-Lasheras, B., Garcia del Rio, A., Antonana-Vildosola, A., Bruzzone, C., Bizkarguenaga, M., Embade, N., Abrescia, N. G. A., Mato, J. M., Millet, O., Palazon, A.
10.1101/2020.07.28.20162941 — Posted: 2020-07-29
Rapid, sensitive and specific SARS coronavirus-2 detection: a multi-center comparison between standard qRT-PCR and CRISPR based DETECTR.
Brandsma, E., Verhagen, H. J., van de Laar, T. J. W., Claas, E. C. J., Cornelissen, M., van den Akker, E.
10.1101/2020.07.27.20147249 — Posted: 2020-07-29
Computer-aided medical microbiology monitoring tool: a strategy to adapt to the SARS-CoV-2 epidemic and that highlights RT-PCR consistency
Mueller, L., Scherz, V., Greub, G., Jaton, K., Opota, O.
10.1101/2020.07.27.20162123 — Posted: 2020-07-29
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors
Uyoga, S., Adetifa, I. M. O., Karanja, H. K., Nyagwange, J., Tuju, J., Wanjiku, P., Aman, R., Mwangangi, M., Amoth, P., Kasera, K., Ng'ang'a, W., Rombo, C., Yegon, C. K., Kithi, K., Odhiambo, E., Rotich, T., Orgut, I., Kihara, S., Otiende, M., Bottomley, C., Mupe, Z. N., Kagucia, E. W., Gallagher, K., Etyang, A., Voller, S., Gitonga, J., Mugo, D., Agoti, C. N., Otieno, E., Ndwiga, L., Lambe, T., Wright, D., Barasa, E., Tsofa, B., Bejon, P., Ochola-Oyier, L. I., Agweyu, A., Scott, J. A. G., Warimwe, G. M.
10.1101/2020.07.27.20162693 — Posted: 2020-07-29 Discussion: Onsite
Serial population based serosurvey of antibodies to SARS-CoV-2 in a low and high transmission area of Karachi, Pakistan
Nisar, M. I., Ansari, N., Amin, M., Khalid, F., Hotwani, A., Rehman, N., Rizvi, A., Memon, A., Ahmed, Z., Ahmed, A., Iqbal, J., Saleem, A. F., Aamir, U. B., Larremore, D. B., Fosdick, B., Jehan, F.
10.1101/2020.07.28.20163451 — Posted: 2020-07-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).